Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Cars.com
CARS
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US OptionsDetailed Quotes
ELV250417C260000
- 0.00
- 0.000.00%
15min DelayClose Apr 4 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest260.00Strike Price0.00Turnover142.72%IV-39.38%PremiumApr 17, 2025Expiry Date168.89Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9823Delta0.0004Gamma2.52Leverage Ratio-0.2221Theta0.0796Rho2.48Eff Leverage0.0334Vega
Elevance Health Newsroom
Truist Financial Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $480
Cantor Fitzgerald Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $485
Truist Financial Sticks to Their Buy Rating for Elevance Health (ELV)
Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $585
Bernstein Adjusts Price Target on Elevance Health to $585 From $511, Keeps Outperform Rating
Wells Fargo Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $478
Wells Fargo Remains a Buy on Elevance Health (ELV)
Argus Research Upgrades Elevance Health(ELV.US) to Buy Rating, Announces Target Price $450
Argus Research Upgrades Elevance Health to Buy, $450 Price Target
Cantor Fitzgerald Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $485
Morgan Stanley Adjusts Price Target on Elevance Health to $405 From $388, Keeps Equalweight Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Elevance Health (ELV) and Genmab (GMAB)
Argus Research Maintains Elevance Health(ELV.US) With Hold Rating
Argus Research Reiterates Hold on Elevance Health, Maintains $405.4 Price Target
J.P. Morgan Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $479
Elevance Health Is Maintained at Overweight by Wells Fargo
Elevance Health Analyst Ratings
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $461 to $511
TD Cowen Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $484
TD Cowen Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $484
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call